# Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

> **NCT00812318** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 45 (actual)

## Conditions studied

- HIV Infection
- Infection, Human Immunodeficiency Virus

## Interventions

- **DRUG:** GSK1265744 10 mg oral solution
- **DRUG:** GSK1265744 5 mg tablet
- **DRUG:** GSK1265744 5 mg tablet

## Key facts

- **NCT ID:** NCT00812318
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-04-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812318, "Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00812318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*